APR 29, 2021 3:05 PM CEST

Molecular pathology clinical and research activities in the COVID-19 era

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute Fondazione G. Pascale, Naples
    BIOGRAPHY

Abstract

The first pandemic wave of COVID-19 in Italy significantly affected the activity of research laboratories. A survey of the Italian Cancer Society (Società Italiana di Cancerologia, SIC) revealed that during the lockdown period (March to May 2021), the impact of COVID-19 pandemic emergency on face-to-face research activities was high, with a complete (47.7%) or partial (36.1%) shutdown of the laboratories. During the pandemic, many cancer research laboratories were also involved in research and clinical activities related to COVID-19. A reduction in the activities of molecular pathology laboratories during the lockdown has also been reported. The emergency has forced a reorganization of the activities of our laboratory, which managed to ensure during the lockdown molecular diagnostic activities similar to 2019. However, this pandemic has also highlighted the need to increase the levels of automation in clinical and research molecular pathology laboratories, also to obviate the limitations of personnel that could occur in situations of emergency. The Genexus system can represent an ideal answer to these needs. In addition to verifying its suitability for molecular pathology tests, we were also able to validate a rapid sequencing protocol of the SARS-CoV-2 viral genome with Genexus that is suitable for monitoring the evolution of variants. Using the AmpliSeq technique, we could also describe for the first time in Italy the B.1.525 variant in February 2021, of which only a hundred cases were known in the world at that time.

Learning Objectives:

1. Impact of pandemic on the organization of research and clinical activities of molecular pathology laboratories Learning objective

2. Relevance of automation in research and diagnostic laboratories


Show Resources
You May Also Like
FEB 24, 2021 10:00 AM PST
C.E. CREDITS
FEB 24, 2021 10:00 AM PST
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
JAN 21, 2021 8:00 AM PST
JAN 21, 2021 8:00 AM PST
Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
MAR 30, 2021 8:00 AM PDT
MAR 30, 2021 8:00 AM PDT
DATE: March 30, 2021 TIME: 08:00am PST In this talk, we will discuss the value of moving towards modular and automated, closed-system technologies designed to enable scalable and cost-effect...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
APR 07, 2021 9:00 AM PDT
C.E. CREDITS
APR 07, 2021 9:00 AM PDT
One challenge pharmaceutical companies face, is moving promising biotherapeutic products into the clinic as fast as safely possible. Devoting the correct amount of time and resources to earl...
JUN 24, 2021 8:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
JUN 24, 2021 8:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: June 24, 2021 Time: 8:00am (PDT), 11:00am (EDT) Cardiovascular disease is a leading health problem, affecting almost 30% of individuals in the developed world, and comprises a wide ran...
Loading Comments...
Show Resources